Creative Music Therapy and Neurodevelopmental Outcomes in Pre-term Infants at 2 Years: A Randomized Controlled Pilot

Friederike Barbara Haslbeck1, Hans Ulrich Bucher1, Dirk Bassler1

  • 1Department of Neonatology, Newborn Research Zurich, University Hospital Zurich, Zurich, Switzerland.

Insights

Creative music therapy (CMT) did not show significant benefits or harm in preterm infants

Area of Science:

  • Pediatric Neurology
  • Developmental Psychology
  • Music Therapy

Background:

  • Preterm birth is a significant risk factor for impaired neurodevelopment in children.
  • Creative music therapy (CMT) is an intervention utilizing musical stimulation and socio-emotional co-regulation.
  • The potential of CMT to mitigate neurodevelopmental deficits in preterm infants requires further investigation.

Purpose of the Study:

  • To assess the feasibility of a randomized clinical pilot trial of CMT in preterm infants.
  • To examine the short-term neurodevelopmental outcomes of preterm infants receiving CMT.
  • To inform future research on the long-term effects of music interventions.

Main Methods:

  • A randomized clinical pilot trial (NCT02434224) was conducted with 82 preterm infants.
  • Infants were randomized to either Creative Music Therapy (CMT) or standard care.
  • CMT involved infant-directed singing provided by a trained music therapist during hospitalization.

Main Results:

  • Fifty-six infants completed follow-up at 2 years of corrected age.
  • No significant beneficial or adverse effects of CMT were observed on standard neurodevelopmental assessments (Bayley-III, neurological examination).

Conclusions:

  • The pilot study demonstrated the feasibility of conducting CMT research in preterm infants.
  • Routine neurodevelopmental measures at 2 years corrected age did not reveal significant effects of CMT.
  • Further research with longer follow-up and more sensitive outcome measures is recommended to explore potential long-term benefits of music interventions.